Hydrochlorothiazide Tablet
Product Images NDC 0615-8449

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 0615-8449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Hctz Tabs 12 5 mg 8449 1)

Chemical structure diagram of hydrochlorothiazide, showing its molecular formula C7H8ClN3O4S2 and molecular weight 297.74.*

FDA Label Image

Principle Display Panel (Hctz Tabs 12 5 mg 8449 2)

Label for Hydrochlorothiazide Tablets USP 12.5 mg, oral tablets packaged by Vangard Labs in Glasgow, KY. The label includes the proprietary and generic name, dosage strength, lot number 8449, and quantity of 30 tablets. Storage instructions specify controlled room temperature (20°-25°C) and dispensing in a light-resistant container. Multiple barcode labels for Hydrochlorothiazide 12.5 mg tablets with identical lot and expiration placeholders are shown for institutional use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.